Ferndale Pharma Group
- Company typePrivate
- Founded1897
- HeadquartersFerndale, United States
- Headcount—
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Ferndale Pharma Group firmographics
Firmographics- Name
- Ferndale Pharma Group
- Legal name
- Ferndale Pharma Group, Inc.
- Website
- https://ferndalepharmagroup.com
- Company type
- Private
- Founded year
- 1897
- Operating status
- Operating
- Ownership category
- akta.pro rank
Ferndale Pharma Group industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Management of Companies and Enterprises (551)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Ferndale Pharma Group is headquartered
LocationHeadquarters
- HQ city
- Ferndale
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Ferndale Pharma Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical and OTC Product Sales: Ferndale Pharma Group generates revenue through the sale of specialty pharmaceutical products, OTC skincare brands, and dermatological solutions. The company develops and manufactures products through its subsidiaries and sells them through retail, hospital, and direct channels.
- Contract Manufacturing Services: Ferndale Contract Manufacturing provides pharmaceutical production, quality control, quality assurance, product development, warehousing, and distribution services to external customers through its FDA-approved facility.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels2 records
Ferndale Pharma Group product offering
Product offeringCore offering
Ferndale Pharma Group is a privately held holding company that develops, manufactures, and distributes specialty dermatology and topical pharmaceutical products through its subsidiaries. It operates Eloquest Healthcare (hospital-focused dermatology and infection-prevention solutions), Ferndale Contract Manufacturing (CDMO services), Ferndale Worldwide (international out-licensing), and Ferndale Pharma UK (dermo-cosmetic skincare and topical therapeutics). Core products include medical adhesives Mastisol and Detachol for clinical use.
Product overview
Ferndale Pharma Group, Inc. is a pharmaceutical holding company founded in 1897 that operates multiple specialty healthcare subsidiaries: Eloquest Healthcare (dermatology specialty serving hospitals with infection prevention and skin integrity products), Ferndale Labs & Contract Manufacturing (FDA-approved CDMO with 100,000+ sq ft facility), Ferndale Worldwide (international out-licensing to 20+ markets), and Ferndale Pharma UK (UK dermatology partner with AESTHETICARE, HEALTH & BEAUTY, and MEDICAL divisions). The group also previously owned OTC skincare brands DerMend and Recticare, sold in January 2026. Products include medical adhesives Mastisol and Detachol. The company provides contract manufacturing, in-licensing, acquisition, and out-licensing partnership opportunities.
Differentiator
Problem solved
Functional benefit
Brands
- Ferndale Labs & Contract Manufacturing: Contract Development and Manufacturing Organization offering pharmaceutical, topical drugs, and related market services for over 30 years.
- Eloquest Healthcare
- Ferndale Worldwide
- Ferndale Pharma UK
Products and services
- Eloquest Healthcare Dermatology specialty subsidiary serving hospitals, healthcare practitioners, and patients with intuitive, cost-effective solutions for prevention of hospital acquired infections, skin integrity, dermal pain minimization, and device adhesion.
- Ferndale Contract Manufacturing (CDMO Services) Contract Development and Manufacturing Organization offering pharmaceutical production, quality control, quality assurance, product development, warehousing, and distribution services for pharma, topical drugs, and related markets. Operated from an FDA-approved 100,000+ sq ft facility in Ferndale, Michigan with over 30 years of manufacturing experience.
- Ferndale Worldwide International business division focused on out-licensing products to local partners globally, exporting finished and bulk products from the US base to more than 20 markets worldwide.
- Ferndale Pharma UK UK-based dermatology and skincare company operating three divisions: AESTHETICARE (professional anti-ageing skincare for aesthetic clinics), HEALTH & BEAUTY (consumer and dermatologist skin solutions), and MEDICAL (skin medicines for pain related to skin procedures). Serves as exclusive UK partner for Cantabria Labs.
- Mastisol Medical adhesive product used in clinical and hospital applications, with Safety Data Sheets maintained through Ferndale Pharma Group.
- Detachol Medical adhesive remover product for clinical applications, with Safety Data Sheets maintained through Ferndale Pharma Group.
Companies that use Ferndale Pharma Group
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles5 records
Ferndale Pharma Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ferndale Pharma Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Cantabria LabscoreFerndale Pharma UK serves as the exclusive UK partner for Cantabria Labs dermatological innovators headquartered in Spain. This is a core strategic partnership for the UK market focused on dermo-cosmetic skincare and specialized skin medicines.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Ferndale Pharma Group competitors and assessment
Company assessmentBroad incumbents
- Patheon (Thermo Fisher Scientific): Global CDMO within Thermo Fisher that provides pharmaceutical development and manufacturing services. Comparable to Ferndale's CDMO subsidiary, though operating at vastly greater scale and breadth.
- Perrigo Company: Major OTC consumer healthcare company with dermatology, skincare, and store-brand products distributed through retailers and pharmacies. Comparable to Ferndale's former OTC skincare franchise (DerMend, Recticare) and retail distribution.
- Catalent: Large global CDMO offering formulation, manufacturing, and packaging services across dosage forms. Comparable to Ferndale Labs & Contract Manufacturing, though at significantly larger scale and broader service mix.
- Bayer (Consumer Health / Pharmaceuticals): Diversified life sciences company with significant dermatology, OTC, and prescription pharma franchises. Overlaps with Ferndale's hospital dermatology, OTC skincare, and pharmacy distribution channels.
Direct peers
- Almirall: European dermatology-focused specialty pharma company with prescription and dermo-cosmetic products across hospital and pharmacy channels. Comparable to Ferndale's specialty dermatology positioning and UK/European footprint.
- Pierre Fabre: French pharmaceutical and dermo-cosmetic group with strong hospital, pharmacy, and aesthetic dermatology presence. Comparable to Ferndale's mix of Rx dermatology, dermo-cosmetics, and hospital channel products.
- Galderma: Pure-play dermatology pharmaceutical company offering prescription and aesthetic/dermo-cosmetic products. Closely comparable to Ferndale Pharma UK's AESTHETICARE and Eloquest's dermatology focus, though at much larger scale.
- Mission Pharmacal: Privately held US specialty pharmaceutical company focused on niche therapeutic areas including dermatology and women's health. Comparable to Ferndale as a private specialty pharma with hospital and physician channel focus.
- Crown Laboratories: Specialty pharmaceutical and dermatology company with branded Rx and OTC skincare products, plus a CDMO business. Directly comparable to Ferndale's mix of hospital-channel dermatology, consumer skincare, and contract manufacturing.
Emerging players
- Aclaris Therapeutics: Clinical-stage and commercial dermatology company developing and commercializing therapies for skin and immune-mediated conditions. Emerging niche player with meaningful overlap to Ferndale's specialty dermatology focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ferndale Pharma Group social profiles
Digital presenceFerndale Pharma Group compliance and trust
Trust signalCompliance1 record
Ferndale Pharma Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ferndale Pharma Group leadership team
Management profileNumber of profiles
Ferndale Pharma Group subsidiaries and ownership
Company hierarchySubsidiaries4 records
Ferndale Pharma Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ferndale Pharma Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ferndale Pharma Group
What does Ferndale Pharma Group do?
Ferndale Pharma Group is a privately held holding company that develops, manufactures, and distributes specialty dermatology and topical pharmaceutical products through its subsidiaries. It operates Eloquest Healthcare (hospital-focused dermatology and infection-prevention solutions), Ferndale Contract Manufacturing (CDMO services), Ferndale Worldwide (international out-licensing), and Ferndale Pharma UK (dermo-cosmetic skincare and topical therapeutics). Core products include medical adhesives Mastisol and Detachol for clinical use.
Is Ferndale Pharma Group a public or private company?
Ferndale Pharma Group is a private company. It is classified as unknown and is currently operating.
When was Ferndale Pharma Group founded?
Ferndale Pharma Group was founded in 1897.
Where is Ferndale Pharma Group based?
Ferndale Pharma Group is headquartered in Ferndale, United States, in the North America region.
How does Ferndale Pharma Group make money?
Two revenue lines are on record. Pharmaceutical and OTC Product Sales are the primary driver. The others are contract Manufacturing Services.
Who are Ferndale Pharma Group's main competitors?
Broad incumbents on record are Patheon (Thermo Fisher Scientific), Perrigo Company, Catalent and Bayer (Consumer Health / Pharmaceuticals). Direct peers are Almirall, Pierre Fabre, Galderma, Mission Pharmacal and Crown Laboratories. Aclaris Therapeutics is listed as an emerging player.
Does Ferndale Pharma Group have an API?
No public API is recorded for Ferndale Pharma Group.
What industry is Ferndale Pharma Group in?
Ferndale Pharma Group's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.